UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 or 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of ~~May~~October 2025

Commission file number: 001-34958

EASON TECHNOLOGY LIMITED

~~23rd~~Room ~~Floor~~612, ~~Lianfa~~6/F, KaiYue ~~International~~Comm Building, No. 2C,

~~128~~Argyle ~~Xudong~~Street, Mongkok ~~Road~~Kowloon, ~~Wuchang~~Hong ~~District~~Kong,

Wuhan City, Hubei Province 430063

People’s Republic of China

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40- F.

Form 20-F ☒ Form 40-F ☐

Notice of ~~Delisting or~~ Failure to Satisfy a Continued Listing Rule

On ~~May~~October 1614, 2025, Eason Technology Limited (“Eason Technology” or the “Company”) received a notice from NYSE Regulation indicating that the Company is not in compliance with the continued listing standards of NYSE American LLC (“NYSE American” or the “Exchange”). The Company ~~failed~~is tobelow ~~timely~~compliance ~~file~~with ~~its~~Section ~~Form~~1003(a)(ii) ~~20-F~~of ~~for~~the NYSE American Company Guide (the ~~period~~“Company ~~ended~~Guide”) since it reported stockholders’ equity of RMB 28 million (approximately USD$3.8 million based on an exchange rate of RMB 7.2993 to US$1.00) as of December 31, 2024, ~~(the~~and ~~“2024~~losses ~~Form~~from ~~20-F”)~~continuing byoperations ~~the~~and/or ~~filing~~net ~~due~~losses ~~date~~in three of ~~May~~its 15four most recent fiscal years ended December 31, ~~2025~~2024 (the “~~Filing Delinquency~~Deficiency”). The Company is ~~now~~also ~~subject~~not tocurrently ~~the~~eligible ~~procedures~~for ~~and~~any ~~requirements~~exemption ~~set forth~~ in Section ~~1007~~1003(a) of the ~~NYSE American~~ Company Guide from the stockholders’ equity requirements.

~~NYSE~~The ~~Regulation notified the~~ Company ~~that~~is ~~NYSE~~now ~~American~~subject ~~will~~to ~~closely monitor~~ the ~~status~~procedures ~~of the Company’s 2024 Form 20-F~~ and ~~any~~requirements ~~subsequent~~set ~~delayed~~forth ~~filings~~in ~~for~~Section a1009 ~~six-month period from the date~~ of the ~~Filing~~Company ~~Delinquency until November 15, 2025 (the “Initial Cure Period”)~~Guide. IfIn ~~the~~connection ~~Company~~with ~~fails to cure the Filing Delinquency within the Initial Cure Period, the Exchange may, in~~ its ~~sole discretion~~Deficiency, ~~allow~~ the Company’s ~~securities~~must tosubmit bea ~~traded~~plan ~~for~~by upNovember ~~to an additional six-month period until May 15~~13, ~~2026~~2025 (~~the~~ “~~Additional~~Plan ~~Cure~~Due ~~Period~~Date”), ~~depending~~advising onof ~~the~~actions ~~Company’s~~it ~~specific~~has ~~circumstances.~~taken Ifor ~~the Exchange determines that an Additional Cure Period is not appropriate, suspension and delisting procedures~~ will ~~commence~~take ~~in accordance with the procedures set out in Section 1010 hereof. If the Exchange determines that an Additional Cure Period of up~~ to ~~six~~regain ~~months~~compliance iswith ~~appropriate and~~ the ~~Company~~continued ~~fails~~listing tostandards ~~file the 2024 Form 20-F and any subsequent delayed filings~~ by ~~the~~April ~~end of that period~~14, ~~suspension~~2027 ~~and~~(“Compliance ~~delisting procedures will generally commence~~Deadline”).

AsIf ~~disclosed in~~ the ~~Form~~Company ~~12b-25~~does ~~filed~~not bysubmit ~~the~~a ~~Company~~compliance onplan ~~April~~or ~~30,~~if ~~2025,~~ the ~~Company~~plan ~~was~~is ~~unable~~not accepted, ~~without~~delisting ~~unreasonable~~proceedings ~~effort~~will orcommence. ~~expense~~Furthermore, toif ~~file~~the ~~its~~plan ~~2024~~is ~~Form~~accepted ~~20-F~~but asthe aCompany ~~result~~is ofnot ain ~~delay~~compliance inwith ~~completing~~the ~~its~~continued ~~financial~~listing ~~statements~~standards ~~for~~by the ~~period~~Compliance ~~ended December 31~~Deadline, ~~2024.~~or ~~The~~if the Company ~~was~~does not ~~able~~make toprogress ~~make~~consistent with the ~~required~~plan ~~filing~~during bythe ~~May~~plan 15period, ~~2025.~~Exchange ~~The~~staff ~~Company~~will isinitiate ~~making~~delisting ~~all~~proceedings ~~efforts~~as toappropriate. ~~file~~The ~~the~~Company ~~2024~~may ~~Form~~appeal ~~20-F~~a asstaff ~~soon~~delisting asdetermination ~~possible~~in ~~and~~accordance ~~within~~with ~~the~~Section ~~Initial~~1010 ~~Cure~~and ~~Period.~~Part ~~However,~~12 ~~there~~of ~~can be no assurance that~~ the Company ~~will ultimately regain compliance with all applicable Exchange listing standards~~Guide.

This delinquency notice has no immediate impact on the listing of the Company’s ADSs, which will continue to be listed and traded on the NYSE American during the cure period subject to continued compliance with the other listing requirements of the NYSE American.

On ~~May~~October 2320, 2025, the Company issued a press release announcing receipt of the delinquency notice. A copy of the press release is ~~attached~~furnished hereto as Exhibit 99.1 and is incorporated herein by reference.

Exhibit Index

Exhibit No.		Description
99.1		Press Release

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Eason Technology Limited
Date: May 23, 2025	By:	/s/ Longwen (Stanley) He
Date: October 20, 2025	By:	/s/ Longwen (Stanley) He
	Name:	Longwen (Stanley) He
	Title:	Chief Executive Officer

Filing Compare · Eason Technology Ltd